Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients

30 Jul 2010

Abstract excerpt

Microarray-based prediction of clinical endpoints may be performed using either a one-color approach reflecting mRNA abundance in absolute intensity values or a two-color approach yielding ratios of fluorescent intensities. In this study, as part of the MAQC-II project, we systematically compared the classification performance resulting from one- and two-color gene-expression profiles of 478 neuroblastoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics and Chromatin Dynamics
Share to Neuroblastoma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20676065
DOI: 10.1038/tpj.2010.53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patientsPMID 20676065Read ↗

Comparison of RNA-seq and microarray-based models for clinical endpoint predictionSemantic proximity Read ↗

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene SignatureSemantic proximity Read ↗

Prognostic Impact of Gene Expression–Based Classification for NeuroblastomaSemantic proximity Read ↗

Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with NeuroblastomaSemantic proximity Read ↗

Algorithmic fusion of gene expression profiling for diffuse large B-cell lymphoma outcome prediction.Semantic proximity Read ↗

Artificial neural network classifier predicts neuroblastoma patients’ outcomeSemantic proximity Read ↗

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk StratificationSemantic proximity Read ↗

Consistency of predictive signature genes and classifiers generated using different microarray platforms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.